Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus ...

Gilead stock looks like a long-term value buy after the pullback, with HIV growth, Yeztugo sales upside, and a safe dividend.

Gilead Sciences (GILD) is scheduled to announce Q1 earnings results on Thursday, May 7th, after market close. The consensus EPS Estimate is $1.91 (+5.5% Y/Y), and the consensus revenue estimate is ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the January 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available this week, for the August 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Check out the latest Gilead Sciences Inc. (GILD) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.